ESMO: Group 1A: Triple Negative Breast Cancer: Patient-Reported Outcomes & Quality of Life
The ESMO Congress 2026 is a leading global oncology event showcasing the latest advances in cancer research and treatment. GRASP provides a unique opportunity for advocates and clinical researchers to […]

